Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2010-2019
Title
Created Date
Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity
06 September 2020
Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines
06 September 2020
Melatonin decreases the expression of inflammation and apoptosis markers in the lung of a senescence-accelerated mice model
02 September 2020
Selenium Enhances the Apoptotic Efficacy of Docetaxel Through Activation of TRPM2 Channel in DBTRG Glioblastoma Cells
27 August 2020
Role of transforming growth factor β1 in the inhibition of gastric cancer cell proliferation by melatonin in vitro and in vivo
26 August 2020
The use of high-dose melatonin in liver resection is safe: first clinical experience
25 August 2020
Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes
25 August 2020
Mitochondrial oxidative stress-induced brain and hippocampus apoptosis decrease through modulation of caspase activity, Ca 2+ influx and inflammatory cytokine molecular pathways in the docetaxel-treated mice by melatonin and selenium treatments
24 August 2020
Melatonin treatment induces apoptosis through regulating the nuclear factor-κB and mitogen-activated protein kinase signaling pathways in human gastric cancer SGC7901 cells
23 August 2020
Clinical pharmacokinetics of melatonin: a systematic review
20 August 2020
Display #
5
10
15
20
25
30
50
100
All
Page 25 of 171
Start
Prev
20
21
22
23
24
25
26
27
28
29
Next
End
Search
Follow us...
Latest
Melatonin, an inhibitory agent in breast cancer
Melatonin: an inhibitor of breast cancer
Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy
Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue
In Vitro Investigations on the Antioxidant Effects of Vitamin D in a Panel of Cancer Cell Lines
Melatonin Inhibits Gastric Cancer Cell Proliferation by Suppressing Exosome miR-27b-3p Expression
Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies
Melatonin and its therapeutic prospects in gastroenterology
Catecholamines Mediate Psychologic Stress-Induced Cancer Progression
Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling
Melatonin Alleviates Acute Respiratory Distress Syndrome by Inhibiting Alveolar Macrophage NLRP3 Inflammasomes Through the ROS/HIF-1α/GLUT1 Pathway
The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
Melatonin Supplementation Improves Pain, Sleep Quality, and Total Plasma Antioxidant Capacity in Women with Fibrocystic Breast Disease: A Randomized, Double-blind, Placebo-controlled Trial
Melatonin as antioxidant, geroprotector and anticarcinogen
Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies
SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma
Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
How effective is chemo therapy?
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Vademecum
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer